Is the outlook grey for WR-2721 as a clinical radioprotector?
- 1 August 1983
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 9 (8) , 1247-1249
- https://doi.org/10.1016/0360-3016(83)90194-3
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Radioprotection of two mouse tumors by WR-2721 in single and fractionated treatmentsInternational Journal of Radiation Oncology*Biology*Physics, 1983
- The potential benefit from a perfect radiosensitizer and its dependence on reoxygenationThe British Journal of Radiology, 1982
- Clinical trials of WR-2721 with radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Experimental radiotherapy with WR-2721 and misonidazoleInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Influence of WR 2721 on the efficacy of radiotherapy and chemotherapy of murine tumorsInternational Journal of Radiation Oncology*Biology*Physics, 1982
- A review of hypoxic cell radiosensitization in experimental tumorsPharmacology & Therapeutics, 1979
- Chemical modification of radiation effectsCancer, 1977
- Differential Radioprotection of Euoxic and Hypoxic Mouse Mammary Tumors by a Thiophosphate CompoundRadiology, 1974
- Radioprotection of tumor and normal tissues by thiophosphate compoundsCancer, 1973
- Effect of Radioprotective Drugs on the Therapeutic Ratio for a Mouse Tumor SystemActa Radiologica: Therapy, Physics, Biology, 1973